Partnering Opportunities

OBJECTIVE

For a partnership to be successful it must be mutually beneficial. Glades is committed to optimizing your existing assets and investments. We would like to offer the opportunity to broaden your development targets, expand your knowledge & experience and to improve your capabilities at little to no incremental investment. We can create more available cash for your business and allow you to focus on your areas of core competency.

We are seeking balanced relationships that will provide incremental profit to all parties.

BUSINESS MODEL

Since our inception in 1991, Glades Pharmaceuticals has followed a three prong strategy for portfolio growth- internal development, strategic alliances, and select product acquisitions. Our commitment to alliance initiatives continues to be a core component of our success. We are actively looking to expand our generic portfolio of products and development projects through in-licensing, acquisition, life cycle management, and co-development partnering transactions. These products and projects span the breadth of generic offerings and provide the optimal return to our partners

OUR TEAM

Our experienced management team has over 100 years of experience in the generic and branded pharmaceutical arena with expertise and success in generic marketing and late-lifecycle brand management. The Glades Pharmaceuticals’ team provides our partners with accomplished leadership and seamless commercialization capabilities. By understanding the dynamics of our customers and competitors in the marketplace, Glades Pharmaceuticals is able to offer a unique collaborative approach for its partners to both develop and commercialize generic products. We continue to develop strategic alliances and acquire products that capitalize on that unique marketplace knowledge.

GLADES AS A PARTNER

Over the past decade Glades has been partnering with large and small branded and generic pharmaceutical companies to accomplish each other’s respective objectives. By choosing Glades as a partner we afford several distinct advantages to our partners. As a private company, we can maintain the level of discretion you seek that can’t be matched by more visible companies. And, Glades’ status as an affiliate of the world’s largest privately-held dermatology company, Stiefel Laboratories, ensures that our partners are secure in working with a reliable, financially stable partner that has a focus on long term objectives. We do what’s right for the business relationship not only this quarter but this year and years to come.

AREAS OF INTEREST

We are interested in partnering with companies that would benefit from:

• Sales and Marketing Promotion of Existing or Soon to be Available Prescription Pharmaceutical Products
• Joint Product Development
• Late Life Cycle Optimization

CONTACT INFORMATION

Darren Alkins
President
678-731-7044
dalkins@glades.com.

Mike McInnis
Director Business Development
678-731-7124
mmcinnis@glades.com

If you are interested in discussing potential partnering opportunities with the Glades Pharmaceuticals team, we encourage you to contact us directly.